ACRO Biomedical Co

ACRO Biomedical Co PP&E per Employee

The PP&E per Employee of ACRO Biomedical Co (ACBM) as of Oct 3, 2026 is 26,900.00 USD. In the previous year, PP&E per Employee was 52,200.00 USD — a change of -48.47% (lower).

PP&E per Employee

26,900.00USD

YoY

-48.47%

Last updated:

PP&E per Employee of ACRO Biomedical Co is 2026 26,900.00 USD. PP&E per Employee of ACRO Biomedical Co was 2025 52,200.00 USD. It decreases by -48.47% lower compared to the previous year.

The ACRO Biomedical Co PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2020
20,000.00 USD
Jan 1, 2021
50,000.00 USD
Jan 1, 2022
30,000.00 USD
Jan 1, 2023
52,200.00 USD
Jan 1, 2024
26,900.00 USD
The ACRO Biomedical Co PP&E per Employee history
YEARPP&E per EmployeeYoY
26,900.00USD-48.47%
52,200.00USD+74.00%
30,000.00USD-40.00%
50,000.00USD+150.00%
20,000.00USD—
Access this data via the Eulerpool API

ACRO Biomedical Co Stock analysis

What does ACRO Biomedical Co do? ACRO Biomedical Co Ltd is a leading company in biomedical technology based in Taipei, Taiwan. The company was established in 2006 and has since successfully established itself in the global market for biomedical products and technologies. The company's vision is to improve people's lives and promote health worldwide through innovative and high-quality products and solutions. Business model: ACRO Biomedical Co Ltd specializes in the development, manufacturing, and marketing of biomedical products and technologies. The company has three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology. Each division focuses on developing products and solutions tailored to the needs of patients and medical professionals. Regenerative Medicine: ACRO Biomedical Co Ltd is a leading provider of regenerative biomedical products. Under this division, the company develops innovative solutions for tissue regeneration, such as bioimplants made from natural tissues and biomaterials to repair or restore damaged tissue. These products are used for the treatment of injuries, chronic diseases, and degenerative conditions. Additionally, ACRO Biomedical Co Ltd has also developed solutions for cosmetic and aesthetic applications. Wound Care: ACRO Biomedical Co Ltd's wound care division specializes in developing products and solutions that help accelerate wound healing, prevent infections, and reduce the risk of complications. The company offers a wide range of products, including antimicrobial and moist wound dressings, which are used for the treatment of acute and chronic wounds such as burns, abrasions, and diabetic foot ulcers. Surgical Technology: ACRO Biomedical Co Ltd's surgical technology division provides healthcare professionals with a wide range of surgical products for various applications, including neurosurgery, plastic surgery, and general surgery. The innovative products offered by ACRO Biomedical Co Ltd for surgical applications include cutting tools, implants, and instruments for minimally invasive procedures. Products: ACRO Biomedical Co Ltd offers a wide range of products for various applications and medical specialties. Some of the company's key products include: - ACL-Bioimplant: A bioimplant for cruciate ligament repair made from human cartilage and biomaterials. - ACRO-CAF: A bone grafting material for bone transplantation. - ACRO-Mixtop: A wound healing agent for the treatment of burns, abrasions, and chronic wounds. - ACRO-OSTEOT: A surgical bone drill for orthopedics and neurosurgery. - ACRO-BioSIS: A tissue adhesive for surgical applications. Summary: ACRO Biomedical Co Ltd is a leading company in biomedical technology that offers innovative solutions for the preservation and restoration of people's health. With its three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology, the company provides a wide range of products and solutions for medical professionals and patients. The company's products are marketed worldwide and are known for their quality, reliability, and effectiveness. ACRO Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ACRO Biomedical Co stock

PP&E per Employee of ACRO Biomedical Co is 26,900.00 USD in 2026.

PP&E per Employee of ACRO Biomedical Co changed from 52,200.00 USD to 26,900.00 USD, representing a -48.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee ACRO Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's ACRO Biomedical Co historically and in real time.

Access this data via the Eulerpool API

Workforce — ACRO Biomedical Co

All Key Metrics — ACRO Biomedical Co